Home » Media Center » News » Gornitzky represents the underwriters, led by Jefferies and Cowen and Company, in NeuroDerm’s USD 77 million follow-on offering on NASDAQ.

July 21, 2015

Gornitzky represents the underwriters, led by Jefferies and Cowen and Company, in NeuroDerm’s USD 77 million follow-on offering on NASDAQ.

PDF

Gornitzky represented the underwriters, led by Jefferies and Cowen and Company, in the USD 77 million follow-on offering of NeuroDerm Ltd. on the NASDAQ Global Market. NeuroDerm Ltd., is a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases.

Jefferies and Cowen and Company acted as joint book-running managers for the offering. Raymond James & Associates and Roth Capital Partners acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner) and Ari Fried (Partner).

Gornitzky represents the underwriters, led by Jefferies and Cowen and Company, in NeuroDerm’s USD 77 million follow-on offering on NASDAQ.

KEY CONTACTS

Chaim Friedland

Ari Fried

RELATED PRACTICES

RELATED NEWS & PUBLICATIONS

Precedent-Setting Decision: Development Improvement Plans Within 100 Meters of the Shoreline

The Importance of Incoterms in International Trade

The war has had a major impact on foreign investments

Success in the Appeals Committee

Ronit Rozenstein-Barel delivers Lecture at the 2024 Energy and Business Conference

Yaron Elhawi Appointed as Debt Settlement Administrator for Kalit Sitbon Ltd.

Nona Lerner Wins the Client Choice Award in Arbitration

New EU Design Legislation: Modernizing Protection for the Digital Era

New Proposed Legislative Tax Reform regarding Corporate Reorganizations

Our Impact

Aviram Handel – Lecture at the Conference of the Court Administration for Legal Assistants at the Tel Aviv District Court